A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer

Autor: Gaponova A., Nikonova A., Deneka A., Kopp M., Kudinov A., Skobeleva N., Khazak V., Ogawa L., Cai K., Duncan K., Duncan J., Egleston B., Proia D., Boumber Y., Golemis E.
Rok vydání: 2016
Předmět:
Zdroj: SCOPUS10780432-2016-22-20-SID84991577399
Popis: ©2016 AACR.Purpose: Small cell lung cancer (SCLC) is a highly aggressive disease representing 12% to 13% of total lung cancers, with median survival of
Databáze: OpenAIRE